After Signing Pact With Chinese Regulators, U.S. Pharmacopeia Seeks To Develop New Tests To Help Prevent Deadly Episodes of Adulteration

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.